U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Public Workshop on COVID-19 Lessons Learned: Clinical Evaluation of Therapeutics - 09/28/2021 - 09/28/2021
  1. News & Events for Human Drugs

Workshop

Event Title
Public Workshop on COVID-19 Lessons Learned: Clinical Evaluation of Therapeutics
September 28, 2021

Scheduled

Date:
September 28, 2021
Time:
1:00 PM - 5:30 PM ET


The purpose of this public workshop is to share lessons learned from the Federal COVID-19 Response or Countermeasures Acceleration Groups (formerly known as Operation Warp Speed) to bring relevant therapeutics to use in a public health emergency. To learn more about the public workshop, including the agenda, please visit: https://reaganudall.org/news-and-events/events/public-workshop-covid-19-lessons-learned-clinical-evaluation-therapeutics.


FOR MORE INFORMATION

More information about this public workshop, including an agenda, is available on the Reagan-Udall event webpage 
 

PUBLIC COMMENT

Individuals and organizations may submit comments on this public workshop by December 28, 2021 through the public docket.  Please search “COVID-19 lessons learned” on www.regulations.gov. For more information about the comment submission process, please visit the Regulations.gov Frequently Asked Questions page.

CONTACT

Kevin Bugin, PhD
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Email: Kevin.Bugin@fda.hhs.gov

Meghana Chalasani, MHA
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Email: Meghana.Chalasani@fda.hhs.gov

 

 

 

Back to Top